EUVIMEDEUVIMED entdecken
Crossref

A Dual‐Targeting, Multi‐Faceted Biocompatible Nanodrug Optimizes the Microenvironment to Ameliorate Abdominal Aortic Aneurysm

Fandi Mo, Chufan Wang, Shiyi Li, Zheyun Li, Cheng Xiao, Yuchong Zhang, Chengkai Hu, Enci Wang, Peng Lin, Tong Yuan, Ziang Zuo, Weiguo Fu und 3 weitere

Advanced Materials · 2024

DOI: 10.1002/adma.202405761 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Fandi Mo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. Hauptthemen laut MEDLINE: Aortic Aneurysm, Abdominal, Macrophages, Biocompatible Materials, Myocytes, Smooth Muscle. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China, NUS School of Medicine Dean's Office, National Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Abdominal aortic aneurysm (AAA) is a highly lethal cardiovascular disease that currently lacks effective pharmacological treatment given the complex pathophysiology of the disease. Here, single‐cell RNA‐sequencing data from patients with AAA and a mouse model are analyzed, which reveals pivotal pathological changes, including the M1‐like polarization of macrophages and the loss of contractile function in smooth muscle cells (SMCs). Both cell types express the integrin αvβ 3, allowing for their dual targeting with a single rationally designed molecule. To this end, a biocompatible nanodrug, which is termed EVMS@R‐HNC, that consists of the multifunctional drug everolimus (EVMS) encapsulated by the hepatitis B virus core protein modifies to contain the RGD sequence to specifically bind to integrin αvβ 3 is designed. Both in vitro and in vivo results show that EVMS@R‐HNC can target macrophages as well as SMCs. Upon binding of the nanodrug, the EVMS is released intracellularly where it exhibits multiple functions, including inhibiting M1 macrophage polarization, thereby suppressing the self‐propagating inflammatory cascade and immune microenvironment imbalance, while preserving the normal contractile function of SMCs. Collectively, these results suggest that EVMS@R‐HNC presents a highly promising therapeutic approach for the management of AAA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Aneurysm, AbdominalMacrophagesBiocompatible MaterialsMyocytes, Smooth MuscleAnimalsHumansMiceEverolimusIntegrin alphaVbeta3NanoparticlesDisease Models, AnimalOligopeptides

Stichwörter der Autor:innen

abdominal aortic aneurysmautophagymacrophage polarizationsingle cell RNA sequencingsmooth muscle cell dysfunctionvirus‐like nanocage

Substanzen

Biocompatible MaterialsEverolimusIntegrin alphaVbeta3Oligopeptides

Autor:innen und Institutionen

  • Department of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Vascular Surgery Institute of Fudan University, Fudan University, Shanghai, 200032, China.
  • National Clinical Research Center for Interventional Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Department of Vascular Surgery (Xiamen), Zhongshan hospital, Fudan University, Xiamen, 361015, China.
  • Key Laboratory of Biomedical Engineering of Fujian Province University/Research Center of Biomedical Engineering of Xiamen, Department of Biomaterials, College of Materials, Xiamen University, Xiamen, 361005, China.
  • Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, National University of Singapore, S…

ORCID-Profile: Xiaoyuan Chen

Förderung

  • National Natural Science Foundation of China
  • NUS School of Medicine Dean's Office
  • National Medical Research Council
  • Singapore Ministry of Education
  • National Research Foundation

Zitieren

APA

Mo, F., Wang, C., Li, S., Li, Z., Xiao, C., Zhang, Y., Hu, C., Wang, E., Lin, P., Yuan, T., Zuo, Z., Fu, W., Chen, X., Ren, L., & Wang, L. (2024). A Dual‐Targeting, Multi‐Faceted Biocompatible Nanodrug Optimizes the Microenvironment to Ameliorate Abdominal Aortic Aneurysm. Advanced Materials. https://doi.org/10.1002/adma.202405761

Vancouver

Mo F, Wang C, Li S, Li Z, Xiao C, Zhang Y, et al. A Dual‐Targeting, Multi‐Faceted Biocompatible Nanodrug Optimizes the Microenvironment to Ameliorate Abdominal Aortic Aneurysm. Advanced Materials. 2024. doi:10.1002/adma.202405761

BibTeX
@article{Mo2024,
  author = {Mo, Fandi and Wang, Chufan and Li, Shiyi and Li, Zheyun and Xiao, Cheng and Zhang, Yuchong and Hu, Chengkai and Wang, Enci and Lin, Peng and Yuan, Tong and Zuo, Ziang and Fu, Weiguo and Chen, Xiaoyuan and Ren, Lei and Wang, Lixin},
  title = {A Dual‐Targeting, Multi‐Faceted Biocompatible Nanodrug Optimizes the Microenvironment to Ameliorate Abdominal Aortic Aneurysm},
  journal = {Advanced Materials},
  year = {2024},
  doi = {10.1002/adma.202405761}
}
Kostenlos starten →